{"nct_id":"NCT05360238","title":"Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL","status":"TERMINATED","status_verified_date":"2023-12","start_date":"2022-05-24","start_date_type":"ACTUAL","primary_completion_date":"2024-04-12","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-12","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MBIO"]}